What Are the Current Challenges in Nanotechnology-Enhanced PDT?
Despite the promising potential, there are several challenges that need to be addressed:
Biocompatibility: Ensuring that nanoparticles are non-toxic and biocompatible is crucial for safe application in humans. Regulatory Approval: The complex nature of nanoparticle systems poses challenges for regulatory approval and standardization. Tumor Heterogeneity: The diverse nature of tumors can affect the distribution and efficacy of nanoparticles, requiring personalized approaches. Cost and Scalability: Developing cost-effective and scalable manufacturing processes for nanoparticle-based PDT systems is essential for widespread clinical adoption.